BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• 

  Career Advice

  Breaking Into Biotech: What You Must Know to Enter Industry

  Candidates looking to enter biotech should focus on cultivating key skills, thoughtfully crafting their resumes and putting their best, most authentic foot forward in interviews. An internship, co-op or fellowship won’t hurt, either.

  October 31, 2024

   · 

  6 min read

   · 

  Angela Gabriel
• 

  Pipeline

  Amgen Whets Investors’ Appetites for MariTide Obesity Data by End of Year

  While Amgen’s third-quarter financial results on Wednesday were “somewhat uneventful,” investors continue to be focused on the highly anticipated MariTide Phase II results slated for late 2024, according to BMO Capital Markets analyst Evan Seigerman.

  October 31, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Earnings

  AbbVie Beats Q3 Estimates as Skyrizi, Rinvoq Pick Up Slack for Humira

  AbbVie’s Humira missed Wall Street’s expectations in the third quarter but Skyrizi and Rinvoq’s continuing outperformance demonstrated the overall strength of its immunology franchise.

  October 31, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Layoffs

  Compass Delays Pivotal Trial Readouts for Psilocybin in Depression, Lays Off 30% of Staff

  In another delay for the psychedelic treatment space, Compass Pathways announced adjusted timelines for two Phase III trials of its psilocybin to address treatment-resistant depression.

  October 31, 2024

   · 

  2 min read

   · 

  Heather McKenzie
• 

  GLP-1

  FDA Says All Doses of Novo’s Ozempic, Wegovy Now Available

  Wednesday’s update to the regulator’s drug shortage database is good news for Novo Nordisk, which has struggled to keep up with demand for the blockbuster GLP-1 drugs.

  October 31, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Earnings

  Merck Lowers Full-Year Sales Guidance Despite Strong Overall Q3 Results

  Offsetting Merck’s growth in the third quarter were disappointing revenues from its HPV vaccine Gardasil and type 2 diabetes pill Januvia, with the company on Thursday narrowing its 2024 sales and adjusted profit outlooks.

  October 31, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  RTI Surgical celebrates expansion of Tutoplast® Tissue Sterilization Process facility

  October 31, 2024

   · 

  2 min read
• Press Releases

  EAACI Unveils Groundbreaking Guidelines for IgE-Mediated Food Allergy Management

  October 31, 2024

   · 

  2 min read
• Press Releases

  Leal Therapeutics Announces $45 Million Financing to Progress Novel Therapies for Patients with Major Neurodegenerative and Neuropsychiatric Disorders

  October 31, 2024

   · 

  3 min read
• Press Releases

  Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention Month

  October 31, 2024

   · 

  9 min read